Zhang Xixue, Wei Jionglin, Song Xiaoxing, Zhang Yuhao, Qian Weiqing, Sheng Lu, Shen Zhoujun, Yang Lvjun, Dong Rong, Gu Weidong
Department of Anesthesiology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Department of Anesthesiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Trials. 2016 Oct 10;17(1):488. doi: 10.1186/s13063-016-1609-5.
Robot-assisted laparoscopic radical prostatectomy and robot-assisted radical cystectomy have gradually become the preferred choices for urologists as they allow surgeons to perform complex procedures more precisely and effectively. The pneumoperitoneum, which is normally applied in these surgeries to provide visual clarity and space to perform the procedure, may cause hemodynamic disturbance, potentially myocardial injury. Thus surgeons have recently considered opting for the low-pressure pneumoperitoneum to lower this negative impact. Herein we describe a protocol for a clinical trial to compare the impact of prolonged low-pressure and standard-pressure pneumoperitoneum on myocardial injury after robot-assisted surgery.
METHODS/DESIGN: This study is designed to be a bicenter clinical trial. In total 280 patients scheduled to undergo robot-assisted laparoscopic radical prostatectomy or robot-assisted radical cystectomy will be enrolled and randomized into two groups, with standard- (12-16 mmHg) and low-pressure (7-10 mmHg) pneumoperitoneum, respectively. Troponin T will be measured as the primary endpoint to assess the extent of myocardial injury. Nt-proBNP and hemodynamic indexes will also be recorded for further analysis.
The significance of this study is emphasized by the fact that there are few studies that have focused on the impact of prolonged pneumoperitoneum on myocardial injury, which is relevant to postoperative mortality. We hope that the conclusions drawn from this study could provide reference and basis to the future of the pneumoperitoneum in clinical practice.
Registered at https://www.clinicaltrials.gov with the Identifier NCT02600481 on November 5, 2015.
机器人辅助腹腔镜前列腺癌根治术和机器人辅助根治性膀胱切除术已逐渐成为泌尿外科医生的首选,因为它们使外科医生能够更精确、有效地进行复杂手术。通常在这些手术中应用的气腹,用于提供视觉清晰度和操作空间,可能会引起血流动力学紊乱,潜在地导致心肌损伤。因此,外科医生最近考虑选择低压气腹以降低这种负面影响。在此,我们描述一项临床试验方案,以比较延长的低压气腹和标准压力气腹对机器人辅助手术后心肌损伤的影响。
方法/设计:本研究设计为一项双中心临床试验。总共280例计划接受机器人辅助腹腔镜前列腺癌根治术或机器人辅助根治性膀胱切除术的患者将被纳入并随机分为两组,分别采用标准压力(12 - 16 mmHg)和气腹压力(7 - 10 mmHg)的气腹。将肌钙蛋白T作为主要终点指标来评估心肌损伤程度。还将记录N末端脑钠肽前体(Nt-proBNP)和血流动力学指标以进行进一步分析。
本研究的意义在于,很少有研究关注延长气腹对心肌损伤的影响,而这与术后死亡率相关。我们希望本研究得出的结论能够为临床实践中气腹的未来应用提供参考和依据。
于2015年11月5日在https://www.clinicaltrials.gov注册,标识符为NCT02600481。